StemCell Institute Inc. (TYO:7096)
Japan · Delayed Price · Currency is JPY 1,017.00
-2.00 (-0.20%)
Aug 1, 2025, 3:30 PM JST
StemCell Institute Market Cap
StemCell Institute has a market cap or net worth of 10.42 billion as of August 1, 2025. Its market cap has decreased by -36.87% in one year.
Market Cap
10.42B
Enterprise Value
7.74B
Revenue
2.68B
Ranking
n/a
PE Ratio
27.05
Stock Price
1,017.00
Market Cap Chart
Since June 25, 2021, StemCell Institute's market cap has decreased from 21.16B to 10.42B, a decrease of -50.75%. That is a compound annual growth rate of -15.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 10.42B | -21.10% |
| Dec 30, 2024 | 13.21B | -39.88% |
| Dec 29, 2023 | 21.97B | -17.47% |
| Dec 30, 2022 | 26.62B | 9.16% |
| Dec 30, 2021 | 24.39B | 15.25% |
| Jun 25, 2021 | 21.16B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 12.08T |
| Daiichi Sankyo Company | 6,807.76B |
| Takeda Pharmaceutical Company | 6,586.93B |
| HOYA Corporation | 5,998.27B |
| Otsuka Holdings | 3,938.80B |
| Terumo | 3,781.04B |
| Astellas Pharma | 2,822.42B |
| Shionogi & | 2,166.95B |